Latest News for: oric

Edit

ORIC Steering Committee's meeting held , KUST Industry Expo announced

Urdu Point 20 Aug 2025
<p>KOHAT, (UrduPoint / Pakistan Point News - 20th Aug, 2025) A meeting of the ORIC (Office of Research, Innovation & Commercialization) Steering Committee has been organized at the Kohat ...
Edit

VC KUST chaired meeting of ORIC steering committee

Urdu Point 18 Aug 2025
<p>KOHAT, (UrduPoint / Pakistan Point News - 18th Aug, 2025) The first meeting of the ORIC Steering Committee was held on Monday at Kohat University of Science and Technology (KUST) under the chairmanship of Vice Chancellor Prof.
Edit

ORIC® Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Updates (Form 8-K) (Oric Pharmaceuticals Inc)

Public Technologies 12 Aug 2025
In anticipation of potential initiation of registrational trials in 2026 for ORIC-944 and ORIC-114 (enozertinib), the company has revised its operating plan to substantially reduce investment in discovery research.
Edit

Quarterly Report for Quarter Ending June 30, 2025 (Form 10-Q) (Oric Pharmaceuticals Inc)

Public Technologies 12 Aug 2025
On August 12, 2025, we announced a strategic pipeline prioritization to focus operational and financial resources on the continued advancement of our two lead clinical programs, ORIC-944 and ORIC-114.
Edit

ORIC® Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Updates

Hastings Tribune 12 Aug 2025
Reported potentially best-in-class clinical efficacy and safety data from ongoing Phase 1b trial of ORIC-944 in combination with AR inhibitors for the treatment of patients with mCRPC ... .
Edit

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Hastings Tribune 02 Aug 2025
01, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc.
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Oric Pharmaceuticals Inc)

Public Technologies 02 Jul 2025
) FORM 4 ... 0.5 ... 2 ... Oric Pharmaceuticals, Inc. [ORIC] 5 ... C/O ORIC PHARMACEUTICALS, INC., 240 E ... 6 ... C/O ORIC PHARMACEUTICALS, INC ... Oric Pharmaceuticals Inc published this content on July 02, 2025, and is solely responsible for the information contained herein.
Edit

Supplemental Prospectus (Form 424B3) (Oric Pharmaceuticals Inc)

Public Technologies 24 Jun 2025
the timing, scope and likelihood of regulatory filings and approvals, including timing of IND or CTA applications and final FDA approval of ORIC-944, ORIC-114 and any other future product candidates;.
Edit

Notice of Effectiveness (Form EFFECT) (Oric Pharmaceuticals Inc)

Public Technologies 23 Jun 2025
Oric Pharmaceuticals, Inc ... Oric Pharmaceuticals Inc published this content on June 20, 2025, and is solely ...
Edit

Proxy Results (Form 8-K) (Oric Pharmaceuticals Inc)

Public Technologies 13 Jun 2025
). Item 5.07 Submission of Matters to a Vote of Security Holders. On June 11, 2025, ORIC Pharmaceuticals, Inc ... Steven L ... For ... Oric Pharmaceuticals Inc published this content on June 13, 2025, and is solely responsible for the information contained herein.
Edit

Registration Statement - Specified Transactions (Form S-3) (Oric Pharmaceuticals Inc)

Public Technologies 11 Jun 2025
the timing, scope and likelihood of regulatory filings and approvals, including timing of IND or CTA applications and final FDA approval of ORIC-944, ORIC-114 and any other future product candidates;.
Edit

Bitcoin Bounces Off The Psychological Orice Of $100,000

Coin Idol 06 Jun 2025
Bitcoin (BTC) has lost the current support at $103,000 and is trading in a narrow range below the resistance at $106,000 or the 21-day Simple Moving Average (SMA) barrier. Bitcoin price long-term prediction. bearish ... Key supply zones ... .
Edit

Notice of Sales of Unregistered Securities (Form D) (Oric Pharmaceuticals Inc)

Public Technologies 06 Jun 2025
Oric Pharmaceuticals, Inc ... Oric Pharmaceuticals, Inc ... c/o ORIC Pharmaceuticals, Inc ... c/o ORIC Pharmaceuticals, Inc ... c/o ORIC Pharmaceuticals, Inc ... c/o ORIC Pharmaceuticals, Inc ... c/o ORIC Pharmaceuticals, Inc ... c/o ORIC Pharmaceuticals, Inc.
Edit

Viking in PIPE Investment in ORIC Pharmaceuticals (Cleary Gottlieb Steen & Hamilton LLP)

Public Technologies 02 Jun 2025
). The text version of this document is not available ... Attachments Original document Permalink.
Edit

ORIC® Pharmaceuticals Announces Potentially Best-In-Class Preliminary Efficacy and Safety Data

Hastings Tribune 29 May 2025
Broad and deep PSA responses achieved, with 59% PSA50 response rate (confirmed rate of 47%, and one additional response pending confirmation) and 24% PSA90 response rate (all confirmed) in patients with mCRPC ... .

Article Search

tools
×
×
×
×